ONVO 1 (-2.91%)
US68620A2033Medical Diagnostics & ResearchDiagnostics & Research

Organovo Holdings (ONVO) Competitor Comparison

We are evaluating the key criteria listed to compare Organovo Holdings (ONVO) against its competitors in the Diagnostics & Research industry.

Linearity 3 years - ONVO ranking 51 / 58

These are the competitors of Organovo Holdings in the industry Diagnostics & Research ranked by linearity 3 years
1. IQVIA Holdings IQV
108.68
2. Quest Diagnostics DGX
101.4
3. Agilent Technologies A
70.7
4. Waters WAT
62.83
5. Ortho Clinical Diagnostics Holdings OCDX
33.4
6. Danaher DHR
22.78
7. Mettler-Toledo MTD
19.38
8. Thermo Fisher Scientific TMO
18.46
9. Laboratory Corp of America Holdings LH
18.37
10. PerkinElmer PKI
16.14
11. IDEXX Laboratories IDXX
13.21
12. Syneos Health SYNH
10.68
13. Qiagen QGEN
9.28
14. Sera Prognostics SERA
8.58
15. DexCom DXCM
7.98
16. Heska HSKA
7.67
17. National Research NRC
6.82
18. Natera NTRA
5.97
19. Charles River Laboratories CRL
5.97
20. Anixa Biosciences ANIX
5.94
21. Icon ICLR
5.91
22. SeqLL SQL
5.36
23. Myriad Genetics MYGN
5.01
24. Global Cord Blood CO
4.22
25. Psychemedics PMD
3.56
26. Olink Holding OLK
3.54
27. Sotera Health SHC
3.43
28. Enzo Biochem ENZ
3.13
29. Exact Sciences EXAS
2.99
30. Inotiv NOTV
2.96
31. Illumina ILMN
2.74
32. Trinity Biotech TRIB
2.72
33. Bioventus BVS
2.67
34. Fulgent Genetics FLGT
2.57
35. Precipio PRPO
2.55
36. Neogen NEOG
2.44
37. Neuronetics STIM
2.21
38. MDxHealth MDXH
2.17
39. Co-Diagnostics CODX
2.13
40. NeoGenomics NEO
2.13
41. Interpace Biosciences IDXG
2
42. MaxCyte MXCT
1.97
43. Twist Bioscience TWST
1.95
44. bioAffinity Technologies BIAF
1.95
45. Prenetics Global PRE
1.92
46. Pacific Biosciences of California PACB
1.89
47. Exagen XGN
1.83
48. DarioHealth DRIO
1.82
49. CareDx CDNA
1.82
50. Guardant Health GH
1.8
51. Organovo Holdings ONVO
1.76
52. Lantheus Holdings LNTH
1.74
53. Personalis PSNL
1.67
54. Aspira Womens Health AWH
1.45
55. Biodesix BDSX
1.45
56. Medpace Holdings MEDP
1.4
57. RadNet RDNT
1.29
58. Meridian Bioscience VIVO
0.73

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.